LucianoJCostaMD

Professor of Medicine University of Alabama at Birmingham

Overview of Dr. Costa

Dr. Luciano Costa is a hematologist in Birmingham, AL and is affiliated with multiple hospitals in the area, including University of Alabama Hospital and Central Alabama VA Medical Center-Montgomery. He received his medical degree from Universidade de Sao Paulo Faculty of Medicine and has been in practice 19 years. Dr. Costa accepts several types of health insurance, listed below. He is one of 16 doctors at University of Alabama Hospital and one of 2 doctors at Central Alabama VA Medical Center-Montgomery who specialize in Hematology. He has more than 100 publications and over 500 citings.

Office
619 19th St S
Birmingham, AL 35233
Book by Phone+1(659) 224-3679

Fax+1 205-934-0971

Education & Training

Wayne State University School of MedicineResidency, Internal Medicine, 2007 - 2008
University of ColoradoFellowship, Hematology and Medical Oncology, 2003 - 2006
Universidade de Sao Paulo Faculty of MedicineClass of 1998

Certifications & Licensure

AL State Medical License 2014 - 2024
SC State Medical License 2008 - 2015
MI State Medical License 2007 - 2008
MN State Medical License 2007 - 2008
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology

Clinical Trials

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) Start of enrollment: 2006 Dec 01
Completed
Phase 3
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801) Start of enrollment: 2010 Apr 01
Completed
Phase 2, Phase 3
Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab Start of enrollment: 2010 May 01
Completed
Phase 2
Carfilzomib + High Dose Melphalan as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation Start of enrollment: 2012 May 01
Completed
Phase 1, Phase 2
Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia Start of enrollment: 2013 Aug 27
Completed
Phase 2
Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis Start of enrollment: 2013 Aug 27
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

3 citations
Ide-cel vs standard regimens in triple-class-exposed relapsed and refractory multiple myeloma: updated KarMMa-3 analyses.
Sikander Ailawadhi, Bertrand Arnulf, Krina Patel, Michele Cavo, Ajay K Nooka
Blood. 2024-12-05
Multiple myeloma clinical trials exclude patients with the highest-risk disease: a systematic review of trial exclusion criteria.
Sara Zhukovsky, Joshua White, Rajshekhar Chakraborty, Luciano J Costa, Oliver Van Oekelen
Leukemia & Lymphoma. 2024-12-01
Total (Immuno)Therapy: Version 2.0.
Susan Bal, Luciano J Costa
Blood Cancer Discovery. 2024-11-26

Journal Articles

Second Primary Malignancy After Multiple Myeloma‐Population Trends and Cause‐Specific Mortality
Parameswaran Hari, Luciano J Costa, Saurabh Chhabra, Kelly N Godby, British Journal of Haematology
A Phase II/III Randomized, Multicenter Trial of Prednisone /Sirolimus vs Prednisone/Sirolimus/Calcineurin Inhibitor for Treatment of Chronic Graft-Versus-Host Disease:...
Amin M Alousi, Mukta Arora, Luciano J Costa, Aleksandr Lazaryan, Daniel J Weisdorf, Sunil Abhyankar, Eneida R Nemecek, Haematologica

Abstracts/Posters

Genomic Landscape of Sex Disparities in Multiple Myeloma
Luciano J. Costa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Impact of Novel Agents on Outcomes of Patients with Classical Hodgkin Lymphoma and Primary Treatment Failure
Luciano J. Costa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Depth of Response to Daratumumab (DARA), Lenalidomide, Bortezomib, and Dexamethasone (RVd) Improves over Time in Patients (pts) with Transplant-Eligible Newly Diagnose...
Luciano J. Costa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacy...
Luciano J. Costa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrel...
Luciano J. Costa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined An...
Luciano J. Costa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Second Primary Malignancy Among Patients with Plasma Cell Myeloma Receiving First-Line Lenalidomide-Based Therapy: A Population-Based Analysis
Luciano J. Costa, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Join now to see all

Lectures

Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined An...
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Population-Level Trends in Early Mortality and Overall Survival of Patients with Multiple Myeloma. Are We Facing Stagnation?
61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Phase I/II, open-label, 2-arm study to evaluate safety, tolerability, and clinical activity of GSK2857916 in combination with 2 standard-of-care (SoC) regimens in rela...
2019 ASCO Annual Meeting - 6/1/2019
Efficacy and Updated Safety Analysis of a Safety Run-in Cohort from Griffin, a Phase 2 Randomized Study of Daratumumab ﴾Dara﴿, Bortezomib ﴾V﴿, Lenalidomide ﴾R﴿, and De...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Subsequent Treatment Outcomes of Multiple Myeloma Refractory to CD38-Monoclonal Antibody Therapy
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Join now to see all

Press Mentions

Murtha Cancer Center’s Lecture Focuses on Multiple MyelomaOctober 21st, 2022
Computing Abroad: Andrew Paluch Brings Supercomputing Experience to BrazilJune 23rd, 2021
Gene Expression and Epigenetics Reveal Species-Specific Mechanisms Acting Upon Common Molecular Pathways in the Evolution of Task Division in BeesFebruary 11th, 2021
Join now to see all

Insurance Accepted

BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment